Teva Pharmaceutical Industries LimitedTEVA

$31.48-1.08 (-3.32%)

NYSEHealthcare24:00 UTC

Company snapshot

Market Cap

$37B

Large-cap

-13%

2016 — today

10-Year Price

-32%

2016 — today

52-Week Range

$15.38$36.34

Current $31.48· 77%

Teva Pharmaceutical Industries develops, manufactures, and markets generic, specialty, and biopharmaceutical products across North America, Europe, and international markets. Its portfolio spans sterile items, hormones, and cytotoxic agents in various delivery forms, alongside active pharmaceutical ingredients (APIs). Key therapeutic areas include CNS disorders (Copaxone, AJOVY, AUSTEDO), respiratory ailments (ProAir, QVAR, CINQAIR), and oncology (Bendeka, Treanda). Founded in 1901, the Tel Aviv-based firm also collaborates on long-acting injectables.